À propos
Dr Daniel Krell is a Consultant Oncologist, specialising in colon, upper GI, lower GI and hepatobiliary cancers and neuroendocrine tumours.
He has expertise in the use of chemotherapy, targeted therapy and immunotherapy. Dr Krell is also the clinical lead for the management of patients with cancer of unknown primary. He is a member of the multidisciplinary team for gastro-oesophageal and hepatobiliary cancer at the Royal Free London NHS Foundation Trust. He also holds the position of Clinical Lead for Neuroendocrine Tumour Oncology at The Royal Free Hospital.
Dr Krell completed his medical degree at the University of Leeds in 2003. He later completed his specialist training in oncology at University College London and the Royal Free Hospital. He also holds a DPhil in Clinical Medicine gained from the University of Oxford's Wellcome Trust Centre for Human Genetics, funded by Cancer Research UK and HCA.
Dr Krell remains actively involved in clinical research and trials designed to find new cancer therapies for hepatobiliary, gastrointestinal and neuroendocrine tumours. He has published papers in peer-reviewed journals and has presented his work at both national and international conferences and meetings.
He has expertise in the use of chemotherapy, targeted therapy and immunotherapy. Dr Krell is also the clinical lead for the management of patients with cancer of unknown primary. He is a member of the multidisciplinary team for gastro-oesophageal and hepatobiliary cancer at the Royal Free London NHS Foundation Trust. He also holds the position of Clinical Lead for Neuroendocrine Tumour Oncology at The Royal Free Hospital.
Dr Krell completed his medical degree at the University of Leeds in 2003. He later completed his specialist training in oncology at University College London and the Royal Free Hospital. He also holds a DPhil in Clinical Medicine gained from the University of Oxford's Wellcome Trust Centre for Human Genetics, funded by Cancer Research UK and HCA.
Dr Krell remains actively involved in clinical research and trials designed to find new cancer therapies for hepatobiliary, gastrointestinal and neuroendocrine tumours. He has published papers in peer-reviewed journals and has presented his work at both national and international conferences and meetings.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Daniel Krell
Formation et études
-
2002–2008 MD · Medicine and Surgery
-
2008–2012 Residency · Oncologie
Carrière et postes
-
2012-09–2013-08 Junior consultant
Licences et assurance
Licences médicales
GB — Organización Médica Colegial de España (OMC)
Certifications du conseil
European Board of Oncologie
Assurance responsabilité professionnelle :
AXA Healthcare Liability · 3,000,000 EUR couverture · No claims on file
Procédures réalisées
| Procédure | Code | Total à vie |
|---|---|---|
| GP consultation | 99213 | 946 |
| Annual physical exam | 99395 | 716 |
| Vaccination administration | 90471 | 1,148 |
| Minor procedure (skin) | 17110 | 83 |
Services et tarifs
| Service | Durée | Modalité | Prix |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 540.00 EUR |
Cabinet, équipe & en pratique
Vidéos
Recherche et publications
indice h : 7 · i10 : 15
-
Long-term follow-up of Oncologie across GB
DOI: 10.1158/euroclin.2026.0 · PMID: 39379831 · cité par 186
-
Validation of clinical scoring in Oncologie
DOI: 10.6063/euroclin.2025.1 · PMID: 34571351 · cité par 24
-
Long-term follow-up of Oncologie across GB
DOI: 10.6782/euroclin.2024.2 · PMID: 35646411 · cité par 142
-
Validation of clinical scoring in Oncologie
DOI: 10.9644/euroclin.2023.3 · PMID: 30757185 · cité par 44
Conférences invitées
- Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
- Single-centre experience in Oncologie National Society Meeting · London · 2023 · oral abstract
Récompenses et adhésions
Récompenses
- 🏆 Top-rated Oncologie — London · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Adhésions à des sociétés
- WONCA Europe — Family Doctors — Member · Depuis 2013
- national college of family doctors — Member · Depuis 2013
- European Union of Medical Specialists (UEMS) — Member · Depuis 2013
Articles de ce médecin
- Patient education Patient guide to Oncologie
- Awareness When should you see a oncologie?
Pour les patients internationaux
- Coordinateur
- Patient liaison · dr.daniel.krell@euroclinics.example
- Assurances internationales acceptées
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Emplacement
1 baliseAvis des patients
48 avis vérifiés4.94
★★★★⯨
48 avis
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.7
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.8
- Value For Money
- 4.9
- Would Recommend Pct
- 98.0
Partagez votre expérience — aidez d'autres patients à trouver le bon médecin. Rédiger un avis →
Avis récents
-
★★★★★ ✓ Vérifié Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Vérifié Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Vérifié Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.